|Agreement labeling||Microbiology Society Publish and Read agreement|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2021 – 31/12/2023|
|Consortia / Institution||IReL|
Approximate range of annual corresponding author publications
|Comments on size/article output||Average article output 2018/19 for the consortium|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Costs are based on subscription plus average OA spend|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Uncapped, unlimited OA publishing|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY mandatory|
||Original research articles|
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||Based on historic subscription spend|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|OVERALL ASSESSMENT AND COMMENTS||IReL are happy to support society publishers proving OA agreements. This agreement provides unlimited access to and open access publishing to the Microbiology portfolio. We will assess and review for future agreements.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|